Inventor · disambiguated record
Namdoo Kim
Also filed as: KIM NAMDOO
3 granted patents·6 pending applications·0 citations·filing 2010–2023
37Inventor score
Top patents by PatentIndex Score
9 records- 0151US2025345329A1Heteroaryl derivative compound and uses thereofVORONOI INC·Filed 2023·Application pending·0 cites
- 0246US2025019373A1Aryl or heteroaryl derivative, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of kinase-related diseasesVORONOI INC·Filed 2022·Application pending·0 cites
- 0346US2024262815A1Heteroaryl derivative, method for preparing same, and pharmaceutical composition comprising same as active ingredientVORONOI INC·Filed 2022·Application pending·0 cites
- 0443US12479847B2Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2DANA FARBER CANCER INST INC·Filed 2020·Granted Nov 25, 2025·0 cites·11 claims
- 0543US12275731B2Azaindole inhibitors of wild-type and mutant forms of LRRK2DANA FARBER CANCER INST INC·Filed 2019·Granted Apr 15, 2025·0 cites·20 claims
- 0637US12240844B2Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related diseaseVORONOI INC·Filed 2020·Granted Mar 4, 2025·0 cites·15 claims
- 0736US2021284647A1N-(3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylphenyl)-5-phenyl-4,5-dihydro-1h-pyrazole-1-carboxamide derivative, and pharmaceutical composition containing same as active ingredient for treating kinase-related diseasesVORONOIBIO INC·Filed 2019·Application pending·0 cites
- 0835US2012160750A1Membrane module and membrane module assembly, and immersion-type layer-sepa-rating apparatus including sameCHOI WOONG·Filed 2010·Application pending·0 cites
- 0930US2023066011A1Pyrrolopyrimidine derivative, and pharmaceutical composition for preventing or treating protein kinase-related disease comprising same as active ingredientVORONOI CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Namdoo Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →